TrianglePUBLICATIONS · 14656276
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Int J Gynecol Cancer
- Publication date
- 2003 Nov-Dec
- First author
- Kristensen GB
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kristensen GB
- type
- Author
- name
- Vergote I
- type
- Author
- name
- Stuart G
- type
- Author
- name
- Del Campo JM
- type
- Author
- name
- Kaern J
- type
- Author
- name
- Lopez AB
- type
- Author
- name
- Eisenhauer E
- type
- Author
- name
- Aavall-Lundquist E
- type
- Author
- name
- Ridderheim M
- type
- Author
- name
- Havsteen H
- type
- Author
- name
- Mirza MR
- type
- Author
- name
- Scheistroen M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kristensen GB
- type
- Author
- name
- Vergote I
- type
- Author
- name
- Stuart G
- type
- Author
- name
- Del Campo JM
- type
- Author
- name
- Kaern J
- type
- Author
- name
- Lopez AB
- type
- Author
- name
- Eisenhauer E
- type
- Author
- name
- Aavall-Lundquist E
- type
- Author
- name
- Ridderheim M
- type
- Author
- name
- Havsteen H
- type
- Author
- name
- Mirza MR
- type
- Author
- name
- Scheistroen M
- type
- Author
- bibliography ids
- nci-bib-f5749d3cdf708c9eebd2bab6
- book metadata
- content sha256
- 14139fdc0f2da925dba09691ad0368bd6ec305722d9b7938425c22620f4a75db
- document type
- citation
- dois
- 10.1111/j.1525-1438.2003.13363.x
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:14656276
- immutable id
- pubmed:14656276@14139fdc0f2da925dba09691ad0368bd6ec305722d9b7938425c22620f4a75db
- journal
- abbreviation
- Int J Gynecol Cancer
- issn electronic
- Source null
- issn print
- 1048-891X
- issue
- Source null
- name
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
- nlm unique id
- 9111626
- pages
- 172-7
- volume
- 13 Suppl 2
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 14656276
- provenance
- batch id
- aee154f17d1b0501fe1f
- provider
- NCBI PubMed ESummary
- record sha256
- cd94b82ce49c153adcddf63287dec0b50d71ab70954adccf8a727c0561e63764
- response sha256
- 75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
- retrieved at
- 2026-09-09T23:45:53.270896+00:00
- publication date
- display
- 2003 Nov-Dec
- precision
- range_or_season
- year
- 2003
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.
Preserved source evidence · Not medical advice